Clinical Trial Update: Acceptability of Hepatitis B Vaccination in General Population

View source ↗

Summary

A completed clinical trial evaluation of the acceptability of Hepatitis B vaccination in the general population, sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Status: COMPLETED